Vyriad is a biotechnology company based in Rochester, MN that is dedicated to developing targeted cancer therapies using engineered viruses. Their oncolytic viruses selectively attack cancer cells and stimulate immune responses to prevent cancer recurrence, with ongoing clinical trials in collaboration with renowned research institutions and pharmaceutical companies.
With a focus on genetic modification, Vyriad programs viruses to better target and infect cancer cells, deliver therapeutic payloads, and mobilize the immune system. Their oncolytic viruses are designed to be safe, trackable, and generate immunological memory, offering potential as a backbone therapy for various cancers and potentially providing patients with a single-shot cure.
Generated from the website